# RIGEL PHARMACEUTICALS INC (RIGLXXXX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RIGLXXXX/

- Reporting holders: 1
- Reported value: $1
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [HUNTINGTON NATIONAL BANK](https://holderbook.com/funds/49205-huntington-national-bank/) | $1 | 1 | 0.0% | 11 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $1 |
| Q1 2026 | 9 | $99.4K |
| Q4 2025 | 9 | $2.0M |
| Q3 2025 | 5 | $929.3K |
| Q2 2025 | 4 | $18.0K |
| Q1 2025 | 5 | $15.9K |
| Q4 2024 | 5 | $20.4K |
| Q3 2024 | 4 | $11.8K |
| Q2 2024 | 8 | $90.1K |
| Q1 2024 | 117 | $208.0M |
| Q4 2023 | 113 | $176.6M |
| Q3 2023 | 106 | $115.4M |